Moreover, these DCs were highly able to capture tumor antigens and to upregulate co-stimulatory molecules in order to prime naïve T cells and differentiate them into tumor-specific CD8+ T cells (Tomita et al., 2019). Here, CD8A is linked to neoplasm.